“…Nucleic acid (NA) aptamers are short, single-stranded oligonucleotides generated by an in vitro technique termed SELEX (Systematic Evolution of Ligands by EXponential enrichment). − Aptamers have a unique tertiary structure with high affinity and specificity for targets, such as small molecules, ions, proteins, cells, bacteria, and viruses. − With these merits, aptamers are commonly referred to as chemical antibodies (Abs). , However, compared to Abs, aptamers have a wider range of targets and can be selected from toxins, nonimmunogenic substances, and other small molecules. ,, In addition, aptamers have several superior advantages, including a small molecular weight, low immunogenicity, ease of synthesis and modification, and high batch-to-batch stability . Such advantages afford aptamers with broad application prospects in metal ion detection, biosensing, − bioimaging, drug delivery, and cancer therapy. , They can, moreover, act as signal mediators, agonists, or antagonists to regulate the growth and behavior of target cells, as well as form aptamer–drug conjugates through drug modification. − …”